Veterinary Vaccines Market - Global Outlook and Forecast 2021-2027

Publisher Name :
Date: 15-Dec-2021
No. of pages: 113

This report contains market size and forecasts of Veterinary Vaccines in Global, including the following market information:

Global Veterinary Vaccines Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Veterinary Vaccines market was valued at 7184.8 million in 2020 and is projected to reach US$ 9312.3 million by 2027, at a CAGR of 6.7% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Veterinary Vaccines Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Veterinary Vaccines Market Segment Percentages, By Type, 2020 (%)

- Inactivated Vaccines

- Live Attenuated Vaccines

- Conjugate Vaccines

- Toxoid Vaccines

- Recombinant Vaccines

- DNA Vaccines

- Others

China Veterinary Vaccines Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Veterinary Vaccines Market Segment Percentages, By Application, 2020 (%)

- Veterinary Clinic

- Veterinary Hospital

- Veterinary Research Institute

- Retail Pharmacy

- Others

Global Veterinary Vaccines Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Veterinary Vaccines Market Segment Percentages, By Region and Country, 2020 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Veterinary Vaccines Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Veterinary Vaccines Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

- Elanco

- Merck

- Merial

- Zoetis

- Advaxis

- AmpliPhi Biosciences

- Aratana Therapeutics

- ARKO Labs

- Bayer

- CanFel Therapeutics

- Ceva Animal Health

- Colorado Serum

- Epitopix

- Genus

- Hygieia Biological Laboratories

- ImmuCell

- Nexvet

- Nuovo Biologics

- UBI

- Valneva

- Vetoquinol

- Virbac

Veterinary Vaccines Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Veterinary Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Vaccines Overall Market Size
2.1 Global Veterinary Vaccines Market Size: 2021 VS 2027
2.2 Global Veterinary Vaccines Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Veterinary Vaccines Players in Global Market
3.2 Top Global Veterinary Vaccines Companies Ranked by Revenue
3.3 Global Veterinary Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Veterinary Vaccines Companies in Global Market, by Revenue in 2020
3.5 Global Companies Veterinary Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Veterinary Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Veterinary Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Veterinary Vaccines Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Conjugate Vaccines
4.1.5 Toxoid Vaccines
4.1.6 Recombinant Vaccines
4.1.7 DNA Vaccines
4.1.8 Others
4.2 By Type - Global Veterinary Vaccines Revenue & Forecasts
4.2.1 By Type - Global Veterinary Vaccines Revenue, 2016-2021
4.2.2 By Type - Global Veterinary Vaccines Revenue, 2022-2027
4.2.3 By Type - Global Veterinary Vaccines Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Veterinary Vaccines Market Size, 2021 & 2027
5.1.2 Veterinary Clinic
5.1.3 Veterinary Hospital
5.1.4 Veterinary Research Institute
5.1.5 Retail Pharmacy
5.1.6 Others
5.2 By Application - Global Veterinary Vaccines Revenue & Forecasts
5.2.1 By Application - Global Veterinary Vaccines Revenue, 2016-2021
5.2.2 By Application - Global Veterinary Vaccines Revenue, 2022-2027
5.2.3 By Application - Global Veterinary Vaccines Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Veterinary Vaccines Market Size, 2021 & 2027
6.2 By Region - Global Veterinary Vaccines Revenue & Forecasts
6.2.1 By Region - Global Veterinary Vaccines Revenue, 2016-2021
6.2.2 By Region - Global Veterinary Vaccines Revenue, 2022-2027
6.2.3 By Region - Global Veterinary Vaccines Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Veterinary Vaccines Revenue, 2016-2027
6.3.2 US Veterinary Vaccines Market Size, 2016-2027
6.3.3 Canada Veterinary Vaccines Market Size, 2016-2027
6.3.4 Mexico Veterinary Vaccines Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Veterinary Vaccines Revenue, 2016-2027
6.4.2 Germany Veterinary Vaccines Market Size, 2016-2027
6.4.3 France Veterinary Vaccines Market Size, 2016-2027
6.4.4 U.K. Veterinary Vaccines Market Size, 2016-2027
6.4.5 Italy Veterinary Vaccines Market Size, 2016-2027
6.4.6 Russia Veterinary Vaccines Market Size, 2016-2027
6.4.7 Nordic Countries Veterinary Vaccines Market Size, 2016-2027
6.4.8 Benelux Veterinary Vaccines Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Veterinary Vaccines Revenue, 2016-2027
6.5.2 China Veterinary Vaccines Market Size, 2016-2027
6.5.3 Japan Veterinary Vaccines Market Size, 2016-2027
6.5.4 South Korea Veterinary Vaccines Market Size, 2016-2027
6.5.5 Southeast Asia Veterinary Vaccines Market Size, 2016-2027
6.5.6 India Veterinary Vaccines Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Veterinary Vaccines Revenue, 2016-2027
6.6.2 Brazil Veterinary Vaccines Market Size, 2016-2027
6.6.3 Argentina Veterinary Vaccines Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Veterinary Vaccines Revenue, 2016-2027
6.7.2 Turkey Veterinary Vaccines Market Size, 2016-2027
6.7.3 Israel Veterinary Vaccines Market Size, 2016-2027
6.7.4 Saudi Arabia Veterinary Vaccines Market Size, 2016-2027
6.7.5 UAE Veterinary Vaccines Market Size, 2016-2027
7 Players Profiles
7.1 Elanco
7.1.1 Elanco Corporate Summary
7.1.2 Elanco Business Overview
7.1.3 Elanco Veterinary Vaccines Major Product Offerings
7.1.4 Elanco Veterinary Vaccines Revenue in Global (2016-2021)
7.1.5 Elanco Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Veterinary Vaccines Major Product Offerings
7.2.4 Merck Veterinary Vaccines Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Merial
7.3.1 Merial Corporate Summary
7.3.2 Merial Business Overview
7.3.3 Merial Veterinary Vaccines Major Product Offerings
7.3.4 Merial Veterinary Vaccines Revenue in Global (2016-2021)
7.3.5 Merial Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Veterinary Vaccines Major Product Offerings
7.4.4 Zoetis Veterinary Vaccines Revenue in Global (2016-2021)
7.4.5 Zoetis Key News
7.5 Advaxis
7.5.1 Advaxis Corporate Summary
7.5.2 Advaxis Business Overview
7.5.3 Advaxis Veterinary Vaccines Major Product Offerings
7.5.4 Advaxis Veterinary Vaccines Revenue in Global (2016-2021)
7.5.5 Advaxis Key News
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences Corporate Summary
7.6.2 AmpliPhi Biosciences Business Overview
7.6.3 AmpliPhi Biosciences Veterinary Vaccines Major Product Offerings
7.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue in Global (2016-2021)
7.6.5 AmpliPhi Biosciences Key News
7.7 Aratana Therapeutics
7.7.1 Aratana Therapeutics Corporate Summary
7.7.2 Aratana Therapeutics Business Overview
7.7.3 Aratana Therapeutics Veterinary Vaccines Major Product Offerings
7.4.4 Aratana Therapeutics Veterinary Vaccines Revenue in Global (2016-2021)
7.7.5 Aratana Therapeutics Key News
7.8 ARKO Labs
7.8.1 ARKO Labs Corporate Summary
7.8.2 ARKO Labs Business Overview
7.8.3 ARKO Labs Veterinary Vaccines Major Product Offerings
7.8.4 ARKO Labs Veterinary Vaccines Revenue in Global (2016-2021)
7.8.5 ARKO Labs Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Veterinary Vaccines Major Product Offerings
7.9.4 Bayer Veterinary Vaccines Revenue in Global (2016-2021)
7.9.5 Bayer Key News
7.10 CanFel Therapeutics
7.10.1 CanFel Therapeutics Corporate Summary
7.10.2 CanFel Therapeutics Business Overview
7.10.3 CanFel Therapeutics Veterinary Vaccines Major Product Offerings
7.10.4 CanFel Therapeutics Veterinary Vaccines Revenue in Global (2016-2021)
7.10.5 CanFel Therapeutics Key News
7.11 Ceva Animal Health
7.11.1 Ceva Animal Health Corporate Summary
7.11.2 Ceva Animal Health Business Overview
7.11.3 Ceva Animal Health Veterinary Vaccines Major Product Offerings
7.11.4 Ceva Animal Health Veterinary Vaccines Revenue in Global (2016-2021)
7.11.5 Ceva Animal Health Key News
7.12 Colorado Serum
7.12.1 Colorado Serum Corporate Summary
7.12.2 Colorado Serum Business Overview
7.12.3 Colorado Serum Veterinary Vaccines Major Product Offerings
7.12.4 Colorado Serum Veterinary Vaccines Revenue in Global (2016-2021)
7.12.5 Colorado Serum Key News
7.13 Epitopix
7.13.1 Epitopix Corporate Summary
7.13.2 Epitopix Business Overview
7.13.3 Epitopix Veterinary Vaccines Major Product Offerings
7.13.4 Epitopix Veterinary Vaccines Revenue in Global (2016-2021)
7.13.5 Epitopix Key News
7.14 Genus
7.14.1 Genus Corporate Summary
7.14.2 Genus Business Overview
7.14.3 Genus Veterinary Vaccines Major Product Offerings
7.14.4 Genus Veterinary Vaccines Revenue in Global (2016-2021)
7.14.5 Genus Key News
7.15 Hygieia Biological Laboratories
7.15.1 Hygieia Biological Laboratories Corporate Summary
7.15.2 Hygieia Biological Laboratories Business Overview
7.15.3 Hygieia Biological Laboratories Veterinary Vaccines Major Product Offerings
7.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue in Global (2016-2021)
7.15.5 Hygieia Biological Laboratories Key News
7.16 ImmuCell
7.16.1 ImmuCell Corporate Summary
7.16.2 ImmuCell Business Overview
7.16.3 ImmuCell Veterinary Vaccines Major Product Offerings
7.16.4 ImmuCell Veterinary Vaccines Revenue in Global (2016-2021)
7.16.5 ImmuCell Key News
7.17 Nexvet
7.17.1 Nexvet Corporate Summary
7.17.2 Nexvet Business Overview
7.17.3 Nexvet Veterinary Vaccines Major Product Offerings
7.17.4 Nexvet Veterinary Vaccines Revenue in Global (2016-2021)
7.17.5 Nexvet Key News
7.18 Nuovo Biologics
7.18.1 Nuovo Biologics Corporate Summary
7.18.2 Nuovo Biologics Business Overview
7.18.3 Nuovo Biologics Veterinary Vaccines Major Product Offerings
7.18.4 Nuovo Biologics Veterinary Vaccines Revenue in Global (2016-2021)
7.18.5 Nuovo Biologics Key News
7.19 UBI
7.19.1 UBI Corporate Summary
7.19.2 UBI Business Overview
7.19.3 UBI Veterinary Vaccines Major Product Offerings
7.19.4 UBI Veterinary Vaccines Revenue in Global (2016-2021)
7.19.5 UBI Key News
7.20 Valneva
7.20.1 Valneva Corporate Summary
7.20.2 Valneva Business Overview
7.20.3 Valneva Veterinary Vaccines Major Product Offerings
7.20.4 Valneva Veterinary Vaccines Revenue in Global (2016-2021)
7.20.5 Valneva Key News
7.21 Vetoquinol
7.21.1 Vetoquinol Corporate Summary
7.21.2 Vetoquinol Business Overview
7.21.3 Vetoquinol Veterinary Vaccines Major Product Offerings
7.21.4 Vetoquinol Veterinary Vaccines Revenue in Global (2016-2021)
7.21.5 Vetoquinol Key News
7.22 Virbac
7.22.1 Virbac Corporate Summary
7.22.2 Virbac Business Overview
7.22.3 Virbac Veterinary Vaccines Major Product Offerings
7.22.4 Virbac Veterinary Vaccines Revenue in Global (2016-2021)
7.22.5 Virbac Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Veterinary Vaccines Market Opportunities & Trends in Global Market
Table 2. Veterinary Vaccines Market Drivers in Global Market
Table 3. Veterinary Vaccines Market Restraints in Global Market
Table 4. Key Players of Veterinary Vaccines in Global Market
Table 5. Top Veterinary Vaccines Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Veterinary Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Veterinary Vaccines Revenue Share by Companies, 2016-2021
Table 8. Global Companies Veterinary Vaccines Product Type
Table 9. List of Global Tier 1 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Veterinary Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Veterinary Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Veterinary Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2022-2027
Table 30. Elanco Corporate Summary
Table 31. Elanco Veterinary Vaccines Product Offerings
Table 32. Elanco Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 33. Merck Corporate Summary
Table 34. Merck Veterinary Vaccines Product Offerings
Table 35. Merck Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 36. Merial Corporate Summary
Table 37. Merial Veterinary Vaccines Product Offerings
Table 38. Merial Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 39. Zoetis Corporate Summary
Table 40. Zoetis Veterinary Vaccines Product Offerings
Table 41. Zoetis Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 42. Advaxis Corporate Summary
Table 43. Advaxis Veterinary Vaccines Product Offerings
Table 44. Advaxis Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 45. AmpliPhi Biosciences Corporate Summary
Table 46. AmpliPhi Biosciences Veterinary Vaccines Product Offerings
Table 47. AmpliPhi Biosciences Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 48. Aratana Therapeutics Corporate Summary
Table 49. Aratana Therapeutics Veterinary Vaccines Product Offerings
Table 50. Aratana Therapeutics Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 51. ARKO Labs Corporate Summary
Table 52. ARKO Labs Veterinary Vaccines Product Offerings
Table 53. ARKO Labs Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 54. Bayer Corporate Summary
Table 55. Bayer Veterinary Vaccines Product Offerings
Table 56. Bayer Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 57. CanFel Therapeutics Corporate Summary
Table 58. CanFel Therapeutics Veterinary Vaccines Product Offerings
Table 59. CanFel Therapeutics Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 60. Ceva Animal Health Corporate Summary
Table 61. Ceva Animal Health Veterinary Vaccines Product Offerings
Table 62. Ceva Animal Health Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 63. Colorado Serum Corporate Summary
Table 64. Colorado Serum Veterinary Vaccines Product Offerings
Table 65. Colorado Serum Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 66. Epitopix Corporate Summary
Table 67. Epitopix Veterinary Vaccines Product Offerings
Table 68. Epitopix Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 69. Genus Corporate Summary
Table 70. Genus Veterinary Vaccines Product Offerings
Table 71. Genus Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 72. Hygieia Biological Laboratories Corporate Summary
Table 73. Hygieia Biological Laboratories Veterinary Vaccines Product Offerings
Table 74. Hygieia Biological Laboratories Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 75. ImmuCell Corporate Summary
Table 76. ImmuCell Veterinary Vaccines Product Offerings
Table 77. ImmuCell Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 78. Nexvet Corporate Summary
Table 79. Nexvet Veterinary Vaccines Product Offerings
Table 80. Nexvet Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 81. Nuovo Biologics Corporate Summary
Table 82. Nuovo Biologics Veterinary Vaccines Product Offerings
Table 83. Nuovo Biologics Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 84. UBI Corporate Summary
Table 85. UBI Veterinary Vaccines Product Offerings
Table 86. UBI Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 87. Valneva Corporate Summary
Table 88. Valneva Veterinary Vaccines Product Offerings
Table 89. Valneva Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 90. Vetoquinol Corporate Summary
Table 91. Vetoquinol Veterinary Vaccines Product Offerings
Table 92. Vetoquinol Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
Table 93. Virbac Corporate Summary
Table 94. Virbac Veterinary Vaccines Product Offerings
Table 95. Virbac Veterinary Vaccines Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Veterinary Vaccines Segment by Type
Figure 2. Veterinary Vaccines Segment by Application
Figure 3. Global Veterinary Vaccines Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Veterinary Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Veterinary Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Veterinary Vaccines Revenue in 2020
Figure 8. By Type - Global Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 9. By Application - Global Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 10. By Region - Global Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 11. By Country - North America Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 12. US Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 16. Germany Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 17. France Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 24. China Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 28. India Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 30. Brazil Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Veterinary Vaccines Revenue Market Share, 2016-2027
Figure 33. Turkey Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Veterinary Vaccines Revenue, (US$, Mn), 2016-2027
Figure 37. Elanco Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Merck Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Merial Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Zoetis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Advaxis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. AmpliPhi Biosciences Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Aratana Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. ARKO Labs Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Bayer Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. CanFel Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Ceva Animal Health Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Colorado Serum Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Epitopix Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Genus Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Hygieia Biological Laboratories Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. ImmuCell Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Nexvet Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Nuovo Biologics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. UBI Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Valneva Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Vetoquinol Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Virbac Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs